Trial Evaluates Dispepril® Efficacy in Functional Dyspepsia vs. Proton Pump Inhibitors
A clinical trial is underway to assess the efficacy of Dispepril®, a nutraceutical, in treating functional dyspepsia compared to standard PPI therapy.
Asset / Drug
Drug and asset intelligence for Gastroenterology with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.